Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

@article{Hannan2008DrugelutingSV,
  title={Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.},
  author={Edward L. Hannan and Chuntao Wu and Gary D. Walford and Alfred T. Culliford and Jeffrey Gold and Craig R. Smith and Robert S. D. Higgins and Russell E Carlson and Robert H. Jones},
  journal={The New England journal of medicine},
  year={2008},
  volume={358 4},
  pages={
          331-41
        }
}
BACKGROUND Numerous studies have compared the outcomes of two competing interventions for multivessel coronary artery disease: coronary-artery bypass grafting (CABG) and coronary stenting. However, little information has become available since the introduction of drug-eluting stents. METHODS We identified patients with multivessel disease who received drug-eluting stents or underwent CABG in New York State between October 1, 2003, and December 31, 2004, and we compared adverse outcomes (death… 

Figures and Tables from this paper

Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease: Three-Year Follow-Up Results From a Single Institution
TLDR
In a cohort of patients with multivessel disease, CABG was associated with lower rates of death, myocardial infarction, and target-vessel revascularization than drug-eluting stents in a 3-year follow-up.
Drug-eluting stents versus bypass surgery for multivessel coronary disease
TLDR
Focus is placed on the recent data and evidence for long-term outcomes in patients treated with DES or CABG for complex multivessel coronary disease, including unprotected left main disease.
Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease.
TLDR
CABG might be associated with cost-effectiveness and could be still the first revascularization strategy for ULMCA disease in the era of drug-eluting stents.
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
TLDR
Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.
Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention
TLDR
Current evidence from randomized trials, a meta-analysis and several observation studies are reviewed, and the comparative effectiveness of PCI and OPCAB remains uncertain.
Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease
TLDR
Angiographic CR with drug-eluting stent implantation or coronary artery bypass grafting did not improve long-term clinical outcomes in patients with multivessel coronary disease, and this finding supports the strategy of ischemia-guided revascularization.
Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Long-term outcomes of coronary-artery bypass grafting versus stent implantation.
TLDR
For patients with two or more diseased coronary arteries, CABG is associated with higher adjusted rates of long-term survival than stenting.
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
TLDR
In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
TLDR
As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction, however, stenting is associated with a greater need for repeated revascularization.
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
TLDR
It is found that survival at 10 years was similar for CABG and PCI, even among diabetic patients, and the evidence from RCTs on the comparative effectiveness of PCI and CABGs was evaluated.
A Prospective Randomized Trial Comparing Stenting to Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA Trial
TLDR
Both stent implantation and CABG are safe and highly effective treatments to relieve symptoms in patients with isolated, proximal left anterior descending coronary artery stenosis, and both are associated with a low and comparable incidence of death and myocardial infarction.
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
TLDR
As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
TLDR
The extended use of clopidogrel in patients with DES may be associated with a reduced risk for death and death or MI, and the appropriate duration for clopIDogrel administration can only be determined within the context of a large-scale randomized clinical trial.
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.
  • P. Serruys, A. Ong, Dennis J Donohoe
  • Medicine
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2005
TLDR
The low incidence of MACCE and repeat revascularisation in ARTS II suggests that contemporary PCI with sirolimus-eluting stents is safe and efficacious for the treatment of multivessel coronary artery disease.
...
1
2
3
4
5
...